Skip to content

Enteral Formula Tolerance of Standard Tube Feedings

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02312271
Enrollment
102
Registered
2014-12-09
Start date
2014-12-31
Completion date
2017-04-30
Last updated
2017-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteral Feeding

Brief summary

This prospective observational study seeks to assess ability to achieve enteral feeding goals with standard tube feeding formulas.

Interventions

standard tube feeding formulas

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years of age * Currently tolerating enteral feeding * Has enteral access * Requires enteral tube feeding to provide 90% or more of their nutritional needs (without the use of modular(s)) for at least 21 days * Having obtained his/her and/or his/her legal representative's informed consent.

Exclusion criteria

* Condition which contraindicates enteral feeding (i.e. intestinal obstruction) * Lack of enteral access * Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, other) * Currently participating in another conflicting clinical study that would interfere with anticipated endpoints * Judged to be at risk for poor compliance to the study protocol. * Lack of informed consent.

Design outcomes

Primary

MeasureTime frame
Daily percentage of caloric nutritional goal met21 days

Secondary

MeasureTime frame
Daily percentage of protein goal met21 days
GI tolerance21 days
Adverse events and serious adverse events21 days

Countries

Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026